IP Library Granted Patent US 12674187
Granted Patent B2
US 12674187 · App. 17/908,372 · Granted Jul 7, 2026

Gram-positive bacteria of the species

Inventors: Vincent Juillard (Neuilly sur Seine, FR); Rozenn Gardan (Jouy-en-Josas, FR); Mylène Boulay (Villers-le-Bâcle, FR); Véronique Monnet (Montigny-le-Bretonneux, FR)
Assignees: Institut National Des Sciences Et Industries Du Vivant Et De L'Environnement; Institut National De Recherche Pour L'Agriculture, L'Alimentation Et L'Environnement
C12P21/02C12N15/746
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12674187
App. No.
17/908,372
Granted
Jul 7, 2026
Kind
B2
Abstract

The present invention relates to a bacterium, in which the expression and/or the activity of surface proteases is/are inhibited, to its preparation process and to the uses of this bacterium.

Claims (28)

1 . A gram-positive bacterium of the species Streptococcus thermophilus or Lactococcus lactis , wherein the gram-positive bacterium has been modified to decrease or abolish expression or activity of a surface protease by mutagenesis and to have increased production of a heterologous protein of interest as compared to an otherwise identical gram-positive bacterium that has not been modified to decrease or abolish expression or activity of the surface protease,

wherein the surface protease comprises an amino acid sequence having at least 80% sequence identity with the sequence of SEQ ID NO: 1, and

wherein SEQ ID NO: 1 is defined as follows:

I-A-G-T-G-T-I-E-X1-D-G-X2-X3-G-X4-I-G-G-X5-X6-X7-K

wherein

X1 is histidine (H) or lysine (K);

X2 is serine(S), alanine (A) or threonine (T);

X3 is isoleucine (I), leucine (L) or valine (V);

X4 is aspartic acid (D) or glutamine (Q);

X5 is alanine (A) or valine (V);

X6 is aspartic acid (D) or tyrosine (Y); and

X7 is lysine (K) or leucine (L).

2 . The bacterium of to claim 1 , wherein the gram-positive bacterium is of the species Streptococcus thermophilus and, wherein the surface protease comprises an amino acid sequence having at least 70% sequence identity with the sequence of SEQ ID NO: 2 when the sequences are aligned along their entire length.

3 . The bacterium of claim 2 , wherein the gram-positive bacterium has been further modified to decrease or abolish expression and/or activity of at least one other surface protease by mutagenesis as compared to an otherwise identical gram-positive bacterium that has not been modified to decrease or abolish expression or activity of the at least one other surface protease, wherein the at least one other surface protease has:

(i) an amino acid sequence having at least 70% sequence identity with the sequence of SEQ ID NO: 8; or

(ii) an amino acid sequence having at least 70% sequence identity with the sequence of SEQ ID NO: 9.

4 . The bacterium of claim 2 , wherein the gram-positive bacterium has been further modified to decrease or abolish expression and/or activity of at least first and second other surface proteases by mutagenesis as compared to an otherwise identical gram-positive bacterium that has not been modified to decrease or abolish expression or activity of the at least first and second other surface proteases,

(i) wherein the first other surface protease has an amino acid sequence having at least 70% sequence identity with the sequence of SEQ ID NO: 8; and

(ii) wherein the second other surface protease has an amino acid sequence having at least 70% sequence identity with the sequence of SEQ ID NO: 9.

5 . The bacterium of claim 1 , wherein the gram-positive bacterium is of the species Lactococcus lactis and, wherein the surface protease comprises an amino acid sequence having at least 70% sequence identity with the sequence of SEQ ID NO: 3 or with the sequence of SEQ ID NO: 4 when the sequences are aligned over their entire length.

6 . The bacterium of claim 5 , wherein the gram-positive bacterium has been further modified to decrease or abolish expression and/or activity of at least one other surface protease by mutagenesis as compared to an otherwise identical gram-positive bacterium that has not been modified to decrease or abolish expression or activity of the at least one other surface protease, wherein the at least one other surface protease has:

(i) an amino acid sequence having at least 70% sequence identity with the sequence of SEQ ID NO: 10; or

(ii) an amino acid sequence having at least 70% sequence identity with the sequence of SEQ ID NO: 11.

7 . The bacterium of claim 5 , wherein the gram-positive bacterium has been further modified by mutagenesis to decrease or abolish expression and/or activity of at least first and second other surface proteases as compared to an otherwise identical gram-positive bacterium that has not been modified to decrease or abolish expression or activity of the at least first and second other surface proteases,

(i) wherein the first other surface protease has an amino acid sequence having at least 70% sequence identity with the sequence of SEQ ID NO: 10; and

(ii) wherein the second other surface protease has an amino acid sequence having at least 70% sequence identity with the sequence of SEQ ID NO: 11.

8 . The bacterium of claim 1 , wherein the gram-positive bacterium comprises an expression vector containing a DNA fragment encoding the heterologous protein of interest or a DNA fragment encoding the heterologous protein of interest inserted in its chromosome.

9 . A method for producing a heterologous protein of interest, the method comprising culturing the gram-positive bacterium of claim 8 to produce the heterologous protein of interest.